• Hypertrophic Cardiomyopathy (HCM)
  • Vaccines: 2023 Year in Review
  • Eyecare
  • Urothelial Carcinoma
  • Women's Health
  • Hemophilia
  • Heart Failure
  • Vaccines
  • Neonatal Care
  • NSCLC
  • Type II Inflammation
  • Substance Use Disorder
  • Gene Therapy
  • Lung Cancer
  • Spinal Muscular Atrophy
  • HIV
  • Post-Acute Care
  • Liver Disease
  • Biologics
  • Asthma
  • Atrial Fibrillation
  • RSV
  • COVID-19
  • Cardiovascular Diseases
  • Prescription Digital Therapeutics
  • Reproductive Health
  • The Improving Patient Access Podcast
  • Blood Cancer
  • Ulcerative Colitis
  • Respiratory Conditions
  • Multiple Sclerosis
  • Digital Health
  • Population Health
  • Sleep Disorders
  • Biosimilars
  • Plaque Psoriasis
  • Leukemia and Lymphoma
  • Oncology
  • Pediatrics
  • Urology
  • Obstetrics-Gynecology & Women's Health
  • Opioids
  • Solid Tumors
  • Autoimmune Diseases
  • Dermatology
  • Diabetes
  • Mental Health

Managed Healthcare Executive® State of Industry Survey: Addressing Health Disparities Seen As a Long Haul

Publication
Article
MHE PublicationMHE January 2022
Volume 32
Issue 1

Results of our survey show some tempering of expectation for addressing healthcare disparities and what can be accomplished this year.

The COVID-19 pandemic and the police killing of George Floyd brought long-simmering issues of disparities in health and healthcare to a boil in 2020. There have been countless numbers of reports, studies, talks and programs since, and the Biden administration has made addressing healthcare disparities a priority.

But results of our annual State of Industry show that the ascendant aspirations for addressing healthcare disparities may be plateauing.

Almost half (45%) of the 100 respondents to our survey indicated agreement with the statement that addressing healthcare disparities is admirable but will take a long time to demonstrate an effect and 17% indicated agreement with the statement that addressing healthcare disparities is admirable, but chances of success are small. On the other hand, a large minority (43%) indicated that they agree that addressing them is long overdue.

More evidence of the hopes for addressing healthcare disparities are coming down to earth: A slim majority (51%) of the respondents indicated that they don’t foresee their organization taking meaningful steps to address healthcare disparities in 2022. And a sizable minority (42%) indicated they had very low or low expectations for the focus on healthcare disparities resulting in meaningful change in 2022.

Related Videos
Related Content
© 2024 MJH Life Sciences

All rights reserved.